These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype. Walsh MD; Clendenning M; Williamson E; Pearson SA; Walters RJ; Nagler B; Packenas D; Win AK; Hopper JL; Jenkins MA; Haydon AM; Rosty C; English DR; Giles GG; McGuckin MA; Young JP; Buchanan DD Mod Pathol; 2013 Dec; 26(12):1642-56. PubMed ID: 23807779 [TBL] [Abstract][Full Text] [Related]
4. RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer. Matsumoto A; Shimada Y; Nakano M; Oyanagi H; Tajima Y; Nakano M; Kameyama H; Hirose Y; Ichikawa H; Nagahashi M; Nogami H; Maruyama S; Takii Y; Ling Y; Okuda S; Wakai T Oncol Rep; 2020 Jun; 43(6):1853-1862. PubMed ID: 32236609 [TBL] [Abstract][Full Text] [Related]
5. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? Velho S; Moutinho C; Cirnes L; Albuquerque C; Hamelin R; Schmitt F; Carneiro F; Oliveira C; Seruca R BMC Cancer; 2008 Sep; 8():255. PubMed ID: 18782444 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers. Choi YW; Song YS; Lee H; Yi K; Kim YB; Suh KW; Lee D Medicine (Baltimore); 2016 Apr; 95(15):e3321. PubMed ID: 27082577 [TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of BRAF Non-V600E Mutations in Colorectal Cancer: A Retrospective Study of Two Institutions. Shimada Y; Tajima Y; Nagahashi M; Ichikawa H; Oyanagi H; Okuda S; Takabe K; Wakai T J Surg Res; 2018 Dec; 232():72-81. PubMed ID: 30463788 [TBL] [Abstract][Full Text] [Related]
8. Association of RNF43 Genetic Alterations With BRAF Vogel A; Murugesan K; Kendre G; Quintanilha JCF; Ross JS; Brummer T; Saborowski A JCO Precis Oncol; 2024 Feb; 8():e2300411. PubMed ID: 38394466 [TBL] [Abstract][Full Text] [Related]
9. MUC5AC/β-catenin expression and KRAS gene alteration in laterally spreading colorectal tumors. Nakae K; Mitomi H; Saito T; Takahashi M; Morimoto T; Hidaka Y; Sakamoto N; Yao T; Watanabe S World J Gastroenterol; 2012 Oct; 18(39):5551-9. PubMed ID: 23112547 [TBL] [Abstract][Full Text] [Related]
10. Oncogenic mutation in RAS-RAF axis leads to increased expression of GREB1, resulting in tumor proliferation in colorectal cancer. Kochi M; Hinoi T; Niitsu H; Miguchi M; Saito Y; Sada H; Sentani K; Sakamoto N; Oue N; Tashiro H; Sotomaru Y; Yasui W; Ohdan H Cancer Sci; 2020 Oct; 111(10):3540-3549. PubMed ID: 32629543 [TBL] [Abstract][Full Text] [Related]
11. Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis. Minoo P; Moyer MP; Jass JR J Pathol; 2007 Jun; 212(2):124-33. PubMed ID: 17427169 [TBL] [Abstract][Full Text] [Related]
12. Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations. Kim IJ; Kang HC; Jang SG; Kim K; Ahn SA; Yoon HJ; Yoon SN; Park JG Carcinogenesis; 2006 Mar; 27(3):392-404. PubMed ID: 16219636 [TBL] [Abstract][Full Text] [Related]
13. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis. Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107 [TBL] [Abstract][Full Text] [Related]
14. BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients. Chen J; Guo F; Shi X; Zhang L; Zhang A; Jin H; He Y BMC Cancer; 2014 Nov; 14():802. PubMed ID: 25367198 [TBL] [Abstract][Full Text] [Related]
15. Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS. Cannon TL; Randall JN; Sokol ES; Alexander SM; Wadlow RC; Winer AA; Barnett DM; Rayes DL; Nimeiri HS; McGregor KA Cancer Treat Res Commun; 2022; 32():100569. PubMed ID: 35567913 [TBL] [Abstract][Full Text] [Related]
16. High frequency of genes' promoter methylation, but lack of BRAF V600E mutation among Iranian colorectal cancer patients. Naghibalhossaini F; Hosseini HM; Mokarram P; Zamani M Pathol Oncol Res; 2011 Dec; 17(4):819-25. PubMed ID: 21455633 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry is a feasible method to screen BRAF V600E mutation in colorectal and papillary thyroid carcinoma. Zhang X; Wang L; Wang J; Zhao H; Wu J; Liu S; Zhang L; Li Y; Xing X Exp Mol Pathol; 2018 Aug; 105(1):153-159. PubMed ID: 30009773 [TBL] [Abstract][Full Text] [Related]
18. Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study. Wish TA; Hyde AJ; Parfrey PS; Green JS; Younghusband HB; Simms MI; Fontaine DG; Dicks EL; Stuckless SN; Gallinger S; McLaughlin JR; Woods MO; Green RC Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1831-9. PubMed ID: 20570909 [TBL] [Abstract][Full Text] [Related]
19. Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas. Wang J; Li R; He Y; Yi Y; Wu H; Liang Z Mod Pathol; 2020 Dec; 33(12):2591-2601. PubMed ID: 32620917 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling. Hinoue T; Weisenberger DJ; Pan F; Campan M; Kim M; Young J; Whitehall VL; Leggett BA; Laird PW PLoS One; 2009 Dec; 4(12):e8357. PubMed ID: 20027224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]